Atlas Trials

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Clinical trial NCT02154139 · COMPLETED

Trial details

NCT number
NCT02154139
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2005-12-01
Primary completion
2010-03-01
Enrollment
651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.